Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: morphine attending: chief complaint: fevers and relapsed aml major surgical or invasive procedure: you were admitted to the intensive care unit during this hospitalization, but had no major surgical or invasive procedures. history of present illness: 65 yo m with h/o aml d+119 s/p allo-sct presents with febrile neutropenia and fatigue. he was seen in clinic on and was feeling well, his performace status was 100%. his peripheral blood showed 19% atypicals which later were read by pathology as blasts. there was concern for relapse. he was brought back to clinic on for a lab check and had 54% blasts. he reports that 5 days prior to admission he had a temp of 100.6 which quickly resolved. then two days prior to admission he began to feel weak and have chills. this morning his daughter took his temperature and it was 101.2. he still complains of fatigue and weakness. he felt some lightheadedness, but no fainting or loc. he denies cp, sob, cough, diarrhea, dysuria, hematuria, no rectal pain. . in the clinic, he appeared weak and fatigued and given his temperature at home, it was decided that he should be admitted to the hospital. blood cultures and urine cultures were taken. he was given cefepime and vancomycin. past medical history: aml s/p allo sct bph renal stone social history: patient lives with wife and daughter. has 2 sons and 2 daughters. is a retired car salesman. he denies ever smoking and only occasionally drank etoh prior to his diagnosis. family history: sister had breast ca. mother died at 89 and had alzheimers. father died at 79 of cva. physical exam: vs: t 99.9, bp 128/92, hr 80, rr 18 general: fatigued appearing male lying in bed; right chest port site is clean without erythema or edema heent: ncat, anicteric, mildly injected conjunctiva, mmm, oral pharynx clear without erythema or exudate. no ulcers or lesions. cv: rrr, nl s1 s2, no m/r/g lungs: ctab no w/r/r abd: +bs, soft, ntnd extremities: + 1 pitting edema bilaterally lower extremities with r slightly greater than left. no calf tenderness. no clubbing or cyanosis. 2+ dp pulses bilaterally. neuro- a/o x3, bilateral hands with tremor (chronic), cn ii-xii intact skin: very warm skin. hyperpigmented le. pertinent results: studies: cxr: impression: no significant interval change compared to radiograph from . no acute cardiopulmonary process. ct chest: impression: 1. small peripheral basilar consolidation of the left lower lobe which is nonspecific and may represent atelectasis versus early pneumonia. 2. three-mm nodule in the right lower lobe and a 4-mm nodule in the right upper lobe for which attention should be paid on followup examinations. 3. sub-cm exophytic hyperdense lesion within the upper pole of the right kidney which is nonspecific and may represent a hemorrhagic cyst, however mri is indicated on a non-emergent basis for further characterization. brief hospital course: 1. leukemia relapse. mr. was found on admission to have 90% circulating blasts, consistent with a relapse of his leukemia. he was treated with a cycle of decitabine and ultimately started on hydrea for cytoreduction. discussion regarding donor lymphocyte infusion was started and the patient will follow up with his oncologist and dr. for further therapy. . 2. febrile neutropenia on admission, mr. had fever and neutropenia. there was no obvious source for infection given lack of localizing signs or symptoms initially. he did have a portacath which looked clean and intact. he was initially started on cefepime and vancomycin but continued to spike to 102 with occasional rigors. his initially set of blood cultures had bottle of coag negative staph that subsequently cleared after a 14 day course of antibiotics. for possibility of fungal infection, he was treated with caspofungin, and this was later broadened to voriconazole. the patient had recurrent bouts of fever/hypothermia and hypotension requiring micu treatment, but was able to be stabilized with fluids and never required pressors. on , the patient cultured out gram negative rods, that speciated to stenotrophomonas maltophilia. his antibiotic regimen was changed to high dose bactrim iv for a planned 2 week course followed by chronic treatment with po bactrim. . 3. rash- he developed maculopapular rash on legs on - nickel size erythematous raised lesions, which were initially non pruritic but became pruritic. there was concern over sweet's syndrome vs. leukemia cutis. a dermatology consult was obtained and biopsies were taken. the biopsy showed superficial to mid-dermal perivascular mixed lymphocytic and eosinophilic infiltrate with atypical mononuclear cells consistent with blasts and red blood cell extravasation. no vasculitis or neutrophilic infiltrate is seen. a hypersensitivity reaction with infiltration by circulating leukemic cells is favored, however if the eruption becomes more prominent, re-biopsy to exclude the development of leukemia cutis should be considered, as clinically appropriate. over the course of the hospitalization, the rash become less prominent and improved. . 4. disposition: after a prolonged hospitalization, the patient was discharged home to complete the iv bactrim course. he will follow up with his hematologist in for further decitabine and will follow up with dr. for further discussion regarding donor lymphocyte infusion. medications on admission: terazosin hcl 5 mg po hs prednisone 20 mg po daily acyclovir 400 mg po q8h zolpidem tartrate 5 mg po hs:prn fluconazole 200 mg po q24h folic acid 1 mg po daily prilosec 20 mg oral sulfameth/trimethoprim ds 1 tab po qmowefr ursodiol 600 mg po qpm ursodiol 300 mg po qam mycophenolate mofetil 250 mg po bid cyclosporine modified (neoral) 100 mg po q12h glyburide 2.5 mg po bid metoprolol 50 mg po bid lorazepam 1mg qhs prn prednisolone eye gtts hydrea 500mg daily (started on ) discharge medications: 1. zolpidem 5 mg tablet sig: one (1) tablet po hs (at bedtime) as needed. disp:*20 tablet(s)* refills:*0* 2. portcath care portcath care per protocol 3. bactrim 80-400 mg/5 ml solution sig: six hundred (600) mg intravenous every twelve (12) hours for 7 days. disp:*qs * refills:*0* 4. acyclovir 400 mg tablet sig: one (1) tablet po every eight (8) hours. disp:*90 tablet(s)* refills:*2* 5. prednisone 2.5 mg tablet sig: three (3) tablet po bid (2 times a day). disp:*180 tablet(s)* refills:*2* 6. voriconazole 200 mg tablet sig: one (1) tablet po q12h (every 12 hours). disp:*60 tablet(s)* refills:*2* 7. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 8. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po twice a day. disp:*60 capsule, delayed release(e.c.)(s)* refills:*2* 9. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed. 10. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 11. furosemide 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 12. hydroxyurea 500 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 13. bactrim ds 160-800 mg tablet sig: one (1) tablet po once a day: start after iv antibiotics are completed. disp:*30 tablet(s)* refills:*2* 14. glyburide 2.5 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* discharge disposition: home with service facility: critical care systems discharge diagnosis: primary diagnosis: acute myelogenous leukemia relapsed after stem cell transplant febrile neutropenia hypotension rash secondary diagnosis: diabetes mellitus benign prostatic hypertrophy discharge condition: fair, with stable vital signs. discharge instructions: you were admitted with fatigue, fevers and rigors, while having a low immune system (febrile neutropenia). you were found to have a relapse of your leukemia and had a bacteria growing in your blood. you were treated with chemotherapy, decitabine, and hydroxyurea, as well as antibiotics. you will need to complete another week of iv antibiotics, followed by oral antibiotics on an ongoing basis. the antibiotic is called bactrim, and you will take 600mg every twelve hours for seven days by the iv, and then take one double-strength tablet daily from then on. given the nature of your long hospitalization, several medications were changed. in particular, your cyclosporin, cellcept (mmf) were stopped because of your relapse. additionally, your metoprolol was discontinued because your blood pressures have not been elevated. you will find an updated medication list with your discharge paperwork. it is important that you only take your new medicines as prescribed. if you have any fevers (temp>100.4), chills, chest pain, shortness of breath, or any other symptoms of concern to you please call our /oncology clinic or go to the emergency room. followup instructions: you will also follow up with dr. . a follow-up appointment is scheduled at the hospital at 11:00am on . the office phone number is . you will need to make a follow-up appointment with dr. for in two weeks time. his phone number is: . procedure: transfusion of packed cells closed biopsy of skin and subcutaneous tissue injection or infusion of cancer chemotherapeutic substance transfusion of platelets diagnoses: pneumonia, organism unspecified unspecified essential hypertension long-term (current) use of steroids diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) sepsis pulmonary collapse hypotension, unspecified long-term (current) use of insulin rash and other nonspecific skin eruption hypoxemia infection and inflammatory reaction due to other vascular device, implant, and graft personal history of urinary calculi streptococcal septicemia neutropenia, unspecified acute myeloid leukemia, without mention of having achieved remission edema other general symptoms complications of other specified transplanted organ 

Answer: The patient is high likely exposed to